Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #2, February 2002
The Warnings Page: Ephedra Recall in Canada; FDA Investigates Kava; Bristol-Myers, Novartis Issue Warnings
Bayer Lists Stock on New York Exchange Amid Marked Increase in Reported Baycol Deaths, Management Shake-Up
In a Jan. 17 motion for leave to amend their complaint, the plaintiffs in an OxyContin class action in Virginia have requested that the class action allegations be deleted without prejudice in the interest of pursuing individual claims.
Plaintiffs seeking injunctive relief under New York law in a Vioxx/Celebrex class action lawsuit have urged a New York federal court to deny defendants' motion to dismiss
Alleging numerous Baycol-related injuries, three plaintiffs have filed a class action lawsuit in federal court in Arkansas seeking, among other things, to establish
The plaintiffs' steering committee in MDL 1355 has submitted a preliminary trial plan for medical monitoring and restitution class claims, outlining three phases
In an order superseding Pretrial Order No. 15 in the Propulsid MDL, Judge Fallon has established a schedule for the conduct of discovery related to